Fortrea at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Fortrea takes part in 2 sessions at CTAD 2026 in Boston. Its program looks at where Alzheimer's drug development is heading, from biomarker-driven late-stage trial design to a more diverse pipeline of therapeutic hypotheses.

OrganizationCTAD 2026 Attendance
Fortrea
Durham, North Carolina
fortrea.com
CROs & trial services
Contract research organization running clinical trials for drug and device developers; spun off from Labcorp in 2023.
Poster
Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue
Poster
Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Fortrea

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction